Precipio Financials - Benzinga

Precipio Inc

PRPONASDAQ

Trade with Public

Trade with Public

$27.32

0.411.52%

At close: Sep 11, 5:00 PM EST

$27.32

N/A

After Hours: Sep 11, 4:00 PM EST

Overview News Earnings Forecast EventsFinancialsSentiment Ownership Compare Stock Report

Precipio Financials

Precipio (PRPO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Precipio Q2 EPS $(0.12) Down From $0.05 YoY, Sales $7.021M Up From $5.654M YoY

Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.12) per share. This is a 340 percent decrease over earnings of $0.05 per share from the same period last year. The company reported $7.021 million in sales this

Benzinga Newsdesk

PRO
Precipio Q1 EPS $(0.81) Down From $(0.59) YoY, Sales $6.711M Up From $4.929M YoY

Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.81) per share. This is a 37.29 percent decrease over losses of $(0.59) per share from the same period last year. The company reported $6.711 million in sales this

Benzinga Newsdesk

Earnings Scheduled For April 2, 2026

Benzinga Insights

PRO
Precipio Q4 2025 Preliminary Revenue $6.7M, An Increase Of 23% From $5.4M YoY

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces some preliminary (unaudited) financials for Q4-2025 and for its fiscal year 2025.Below are some of the key financial performance metrics

Benzinga Newsdesk

PRO
Precipio Q3 EPS $(0.05) Up From $(0.42) YoY, Sales $6.767M Up From $5.209M YoY

Benzinga Newsdesk

PRO
Precipio Q2 EPS $0.05 Up From $(0.83) YoY, Sales $5.654M Up From $4.441M YoY

Precipio (NASDAQ:PRPO) reported quarterly earnings of $0.05 per share. This is a 106.02 percent increase over losses of $(0.83) per share from the same period last year. The company reported $5.654 million in sales this

Benzinga Newsdesk